Other/unspecified enthesopathies of lower limb, excluding foot

M13_ENTESOPATHYLOWNAS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M76.8, M76.9 Hospital discharge: ICD-9 — 7267B\|7266F\|7266X\|7267X Cause of death: ICD-10 — M76.8, M76.9 Cause of death: ICD-9 — 7267B\|7266F\|7266X\|7267X 2 out of 7 registries used, show all original rules.	3166
4. Check minimum number of events None	3166
5. Include endpoints None	3166
6. Filter based on genotype QC (FinnGen only)	3080

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	M13_ENTESOPATHYLOWNAS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M76[8-9]
HD_ICD_9	7267B\|7266F\|7266X\|7267X
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M76[8-9]
COD_ICD_9	7267B\|7266F\|7266X\|7267X
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other/unspecified enthesopathies of lower limb, excluding foot based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	19066	11159	7830
Only index persons	18272	10791	7481
Unadjusted period prevalence (%)
Whole population	0.28	0.32	0.22
Only index persons	0.35	0.40	0.29
Median age at first event (years)
Whole population	45.48	49.99	39.01
Only index persons	45.16	49.69	38.62

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3080	2067	1013
Unadjusted period prevalence (%)	0.64	0.73	0.46
Median age at first event (years)	51.34	51.47	51.09

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3166: Matched controls
31660

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M79.6

ICD-10 Finland

Pain in limb

4.0

322.4

1834

8095

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

28.7

307.7

539

225

M54.5

ICD-10 Finland

Low back pain

4.2

307.7

1382

4977

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

24.2

307.7

381

178

N03AX16

ATC

[U] pregabalin

5.6

307.7

1022

2466

M48.0

ICD-10 Finland

Spinal stenosis

42.6

307.7

416

112

M54.4

ICD-10 Finland

Lumbago with sciatica

7.2

307.7

790

1396

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

250.3

307.7

1190

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

30.5

307.7

605

243

NGM10

NOMESCO Finland

Fasciotomy of of knee or lower leg

100.6

307.7

381

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

17.0

307.7

292

188

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

74.6

307.7

273

N03AX12

ATC

[U] gabapentin; oral

7.7

307.7

802

1343

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

428.7

307.7

1975

122

N02AX02

ATC

tramadol; systemic, rectal

3.8

304.3

1633

6863

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

92.3

302.1

158

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

9.2

286.4

368

446

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

6.5

282.2

514

920

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

125.2

260.7

132

M70.6

ICD-10 Finland

Trochanteric bursitis

5.0

260.2

657

1576

M25.5

ICD-10 Finland

Pain in joint

3.5

255.0

1438

6081

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

23.4

243.2

177

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

22.8

230.1

169

M47.82

ICD-10 Finland

Other spondylosis, cervical region

21.3

222.3

168

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.5

219.0

469

969

M01AH05

ATC

etoricoxib; oral

3.6

218.2

2352

14206

N06AX21

ATC

duloxetine; oral

4.7

203.5

533

1303

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

3.0

197.2

1658

8519

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

13.8

195.9

185

142

M47.9

ICD-10 Finland

Spondylosis, unspecified

43.4

189.1

113

M43.1

ICD-10 Finland

Spondylolisthesis

27.0

184.8

127

M54.1

ICD-10 Finland

Radiculopathy

14.5

183.6

168

122

N02AJ06

ATC

codeine and paracetamol; systemic

2.9

182.1

1574

8111

N02BF01

ATC

gabapentin; oral

5.9

180.5

346

642

M54.3

ICD-10 Finland

Sciatica

9.0

180.0

230

274

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

10.1

179.7

209

220

M76.0

ICD-10 Finland

Gluteal tendinitis

13.4

176.1

169

133

L03

ICPC

Low back symptom/complaint

2.9

156.7

974

4147

M03BX02

ATC

tizanidine; oral

2.8

155.3

2209

14244

M03BC01

ATC

orphenadrine (citrate); systemic

3.0

154.9

883

3581

M01AB05

ATC

diclofenac; systemic, rectal

2.8

141.2

2300

15513

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.8

136.4

912

3996

R52.2

ICD-10 Finland

Other chronic pain

7.7

136.0

196

269

M76.6

ICD-10 Finland

Achilles tendinitis

6.0

131.4

245

440

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

10.2

130.1

149

153

M02AA07

ATC

piroxicam; topical

2.5

128.1

1251

6561

M54.2

ICD-10 Finland

Cervicalgia

5.0

124.8

287

622

L13

ICPC

Hip symptom/complaint

3.0

124.4

671

2605

A02BC05

ATC

esomeprazole; systemic

2.4

119.8

1407

7957

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.4

119.3

1298

7095

L86

ICPC

Back syndrome with radiating pain

5.9

119.0

221

395

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

15.7

117.4

102

M01AC06

ATC

meloxicam; systemic, rectal

2.4

114.1

1256

6869

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

19.5

113.9

L17

ICPC

Foot/toe symptom/complaint

2.5

111.5

1018

5115

M50.3

ICD-10 Finland

Other cervical disc degeneration

19.4

108.6

M54.6

ICD-10 Finland

Pain in thoracic spine

4.5

107.8

277

656

X59

ICD-10 Finland

Exposure to unspecified factor

2.7

105.5

724

3166

M79.1

ICD-10 Finland

Myalgia

2.9

105.3

578

2249

M01AH01

ATC

celecoxib; oral

2.9

105.3

611

2450

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

104.8

100

A02BC02

ATC

pantoprazole; systemic

2.3

103.5

2194

15540

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

3.3

102.6

446

1517

N06AA09

ATC

amitriptyline; systemic

3.8

102.4

333

938

R51.80

ICD-10 Finland

Headache

2.8

100.3

597

2421

M01AE02

ATC

naproxen; oral, rectal

2.2

99.8

1942

13188

M19.0

ICD-10 Finland

Primary arthrosis of other joints

3.4

99.4

392

1254

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

5.9

99.4

184

327

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.5

99.2

381

1199

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

24.7

98.8

N02BF02

ATC

pregabalin; oral

4.7

96.0

230

514

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.4

94.2

900

4559

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

94.0

864

4303

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.3

93.3

925

4758

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

28.7

92.4

M54.8

ICD-10 Finland

Other dorsalgia

5.7

92.1

177

326

NHL50

NOMESCO Finland

Tenolysis or tenosynovectomy of foot

28.3

90.4

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

13.2

89.8

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

42.2

89.7

N02BE01

ATC

paracetamol; systemic, rectal

3.2

88.5

2859

23517

M79.0

ICD-10 Finland

Rheumatism, unspecified

6.7

87.4

141

218

M79.7

ICD-10 Finland

Fibromyalgia

5.9

87.4

162

288

NHL16

NOMESCO Finland

Tenolysis or tenosynovectomy of achilles tendon

44.0

87.2

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.5

87.1

682

3147

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.1

85.0

387

1346

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.8

84.1

496

1989

H02AB06

ATC

prednisolone; systemic

2.1

83.5

1496

9608

R07.4

ICD-10 Finland

Chest pain, unspecified

2.3

83.1

861

4480

R52.9

ICD-10 Finland

Pain, unspecified

3.2

83.0

369

1265

M45

ICD-10 Finland

Ankylosing spondylitis

33.7

82.9

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

35.2

82.4

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

4.6

81.6

204

471

L16

ICPC

Ankle symptom/complaint

2.8

80.9

453

1766

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

808.6

80.8

R5599

NOMESCO Finland

Other rehabilitation service

6.7

80.5

129

198

M01AX17

ATC

nimesulide; oral

2.3

78.5

738

3674

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

11.2

78.2

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

76.9

1135

6740

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

8.7

76.6

116

Z3226

NOMESCO Finland

Physiotherapist

2.4

76.1

612

2842

A01

ICPC

Pain general/multiple sites

3.2

75.9

319

1056

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

75.4

602

2785

S18

ICPC

Laceration/cut

2.0

75.3

1380

8838

A02BC01

ATC

omeprazole; systemic

2.2

75.2

846

4524

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

75.2

908

4992

M67.8

ICD-10 Finland

Other specified disorders of synovium and tendon

9.7

75.0

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

74.5

734

3718

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

10.1

73.9

M35.7

ICD-10 Finland

Hypermobility syndrome

10.0

73.3

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.7

73.1

243

691

M77.4

ICD-10 Finland

Metatarsalgia

3.4

73.0

276

855

M01AH02

ATC

rofecoxib; oral

2.9

72.7

388

1470

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.6

72.7

259

772

L15

ICPC

Knee symptom/complaint

2.2

72.6

803

4258

M70.7

ICD-10 Finland

Other bursitis of hip

6.0

72.4

130

224

L08

ICPC

Shoulder symptom/complaint

2.3

72.1

717

3641

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.8

71.9

410

1609

X58

ICD-10 Finland

Exposure to other specified factors

2.5

71.8

520

2296

R4110

NOMESCO Finland

Physiotherapy

2.1

70.1

894

4997

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

70.1

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

7.2

69.6

105

151

A02BC03

ATC

lansoprazole; oral

2.1

69.6

854

4704

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

3.0

69.3

336

1207

R03AC02

ATC

salbutamol; inhalant

1.9

67.9

1759

12504

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.9

67.8

360

1358

M77.1

ICD-10 Finland

Lateral epicondylitis

3.0

67.7

328

1177

J01FA10

ATC

azithromycin; systemic

1.9

67.3

1941

14275

R06.0

ICD-10 Finland

Dyspnoea

2.1

67.0

787

4254

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.5

66.8

485

2139

G44.2

ICD-10 Finland

Tension-type headache

2.5

66.5

467

2028

R52.1

ICD-10 Finland

Chronic intractable pain

21.2

66.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

65.8

936

5426

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

26.8

65.5

J01AA02

ATC

doxycycline; systemic

2.1

64.4

2442

19564

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

64.1

801

4421

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

63.7

852

4821

L29

ICPC

Musculoskeletal sympt/complt other

2.9

63.1

314

1142

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.6

62.9

425

1809

L14

ICPC

Leg/thigh symptom/complaint

3.0

62.7

295

1040

ZXA05

NOMESCO Finland

Left side

2.1

62.1

746

4052

XA402

NOMESCO Finland

ENMG

6.8

61.2

144

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

3.5

61.1

224

679

N06AX11

ATC

mirtazapine; oral

1.9

60.7

1058

6543

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

313.6

60.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

60.0

1661

11876

L28

ICPC

Limited function/disability (L)

2.4

60.0

479

2200

N06AX16

ATC

venlafaxine; oral

2.4

59.7

492

2290

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

3.1

59.3

262

890

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

59.2

1305

8685

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.6

58.2

379

1583

ZXA00

NOMESCO Finland

Right side

2.0

58.0

782

4417

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.3

57.4

234

757

M16.1

ICD-10 Finland

Other primary coxarthrosis

2.7

57.4

339

1348

R20.2

ICD-10 Finland

Paraesthesia of skin

3.1

57.0

252

856

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

3.1

57.0

249

840

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

2.6

56.8

380

1607

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

56.4

591

3034

L01

ICPC

Neck symptom/complaint

2.3

55.7

491

2349

R42

ICD-10 Finland

Dizziness and giddiness

2.1

54.9

645

3457

M77.9

ICD-10 Finland

Enthesopathy, unspecified

4.1

53.9

152

384

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

6.5

53.8

141

J02AC01

ATC

fluconazole; systemic

1.8

53.6

1330

9101

N02AA05

ATC

oxycodone; systemic

2.3

52.5

446

2097

J01DB01

ATC

cefalexin; oral

2.1

52.1

2603

21904

NF1AA

NOMESCO Finland

Hip X-ray examination

3.0

52.0

251

895

R01AD09

ATC

mometasone; nasal

1.8

51.7

1476

10484

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.3

51.6

202

637

WX320

NOMESCO Finland

Spinalanesthesy

2.0

51.5

751

4335

UJF32

NOMESCO Finland

Coloscopy

2.0

51.5

724

4128

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

179.6

51.0

M01AB55

ATC

diclofenac, combinations; oral

3.3

50.8

198

623

B01AB05

ATC

enoxaparin; parenteral

1.9

50.7

919

5692

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.9

50.6

256

937

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

50.5

259

955

M01AX05

ATC

glucosamine; oral

2.2

50.3

519

2638

R53

ICD-10 Finland

Malaise and fatigue

2.0

50.2

732

4220

R06AE07

ATC

cetirizine; oral

1.7

49.7

1423

10079

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.4

49.4

376

1683

M01AH03

ATC

valdecoxib; oral

3.2

48.8

198

638

G54.0

ICD-10 Finland

Brachial plexus disorders

5.7

48.8

166

T79.6

ICD-10 Finland

Traumatic ischaemia of muscle

16.6

48.7

J01FA06

ATC

roxithromycin; oral

1.8

48.5

1223

8340

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.6

48.4

314

1304

NHK99

NOMESCO Finland

Other operation on bone of ankle or foot

6.0

48.1

144

M02AA10

ATC

ketoprofen; topical

2.2

48.1

489

2469

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

48.0

SPAT1153

SPAT

Removal of sutures

1.8

47.6

880

5466

M54

ICD-10 Finland

Dorsalgia

2.3

47.3

382

1753

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

47.0

567

3051

M89.0

ICD-10 Finland

Algoneurodystrophy

10.2

46.9

M70.8

ICD-10 Finland

Other soft tissue disorders related to use, overuse and pressure

8.0

45.6

R01AD08

ATC

fluticasone; nasal

1.8

45.5

942

6042

AA1AD

NOMESCO Finland

CT of head and brain

1.9

45.5

711

4179

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

45.4

303

1275

R05

ICPC

Cough

1.9

45.4

735

4370

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.6

45.3

154

443

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.7

45.3

266

1051

NFL30

NOMESCO Finland

Transposition of muscle of hip or thigh

7.7

45.0

R03DC03

ATC

montelukast; oral

2.0

45.0

546

2941

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.6

44.9

152

436

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

4.3

44.8

119

287

J01DA01

ATC

[U] cefalexin

1.7

44.7

1888

14704

L02

ICPC

Back symptom/complaint

2.5

44.2

314

1359

NHL30

NOMESCO Finland

Suture or reinsertion of tendon of foot

8.3

44.1

M01AE01

ATC

ibuprofen; systemic, rectal

2.4

44.0

2880

25596

N04BC05

ATC

pramipexole; oral

2.8

43.9

230

857

N02AJ13

ATC

tramadol and paracetamol; systemic

5.8

43.8

140

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

43.8

1253

8784

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

43.6

304

1304

Z3231

NOMESCO Finland

Registered nurse

1.8

43.5

806

4990

L12

ICPC

Hand/finger symptom/complaint

2.0

43.4

510

2713

A02BA02

ATC

ranitidine; systemic

2.0

43.1

521

2798

R01BA52

ATC

pseudoephedrine, combinations; oral

1.8

42.9

952

6212

N05BA04

ATC

oxazepam; oral

1.8

42.7

779

4794

R60.0

ICD-10 Finland

Localized oedema

2.3

42.7

346

1588

M76.7

ICD-10 Finland

Peroneal tendinitis

9.6

42.5

J01FF01

ATC

clindamycin; systemic

1.8

42.2

810

5059

N01

ICPC

Headache

2.2

41.9

373

1780

R07.3

ICD-10 Finland

Other chest pain

2.4

41.9

297

1284

M23.8

ICD-10 Finland

Other internal derangements of knee

3.5

41.7

150

448

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

5.1

41.6

180

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

41.6

1126

7748

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

41.5

1038

6989

J01MA02

ATC

ciprofloxacin; systemic

1.7

41.4

1080

7355

K30

ICD-10 Finland

Functional dyspepsia

2.2

41.0

360

1708

R06AX27

ATC

desloratadine; oral

1.7

40.9

952

6280

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

91.3

40.9

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

40.7

2257

18670

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.7

40.6

223

851

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

2.0

40.5

473

2505

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

40.4

2218

18272

R01AD58

ATC

fluticasone, combinations; nasal

1.8

40.4

820

5197

H02AB07

ATC

prednisone; oral

2.1

40.3

417

2110

N02AC04

ATC

dextropropoxyphene; oral

4.9

40.3

185

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.0

40.3

188

657

Z50.1

ICD-10 Finland

Other physical therapy

3.2

40.2

167

545

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

40.2

1621

12332

S83.2

ICD-10 Finland

Tear of meniscus, current

2.6

39.9

245

989

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

39.8

399

1995

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.6

39.8

1459

10828

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

3.1

39.8

174

586

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

39.3

749

4654

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

39.3

1711

13236

M13.9

ICD-10 Finland

Arthritis, unspecified

2.6

39.2

239

961

K07.60

ICD-10 Finland

Snapping jaw

2.9

39.2

190

678

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

39.2

330

1537

H02AB04

ATC

methylprednisolone; systemic

2.1

39.1

431

2232

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

39.0

526

2927

N03AE01

ATC

clonazepam; systemic

3.0

38.9

181

631

M01AX01

ATC

nabumetone; oral

3.6

38.9

130

370

L18

ICPC

Muscle pain

3.4

38.8

143

434

S80.0

ICD-10 Finland

Contusion of knee

2.5

38.7

257

1077

Z01.2

ICD-10 Finland

Dental examination

1.6

38.6

1419

10510

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.9

38.6

194

706

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

38.5

848

5490

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

38.5

667

4024

SPAT1301

SPAT

No procedures

1.7

38.2

845

5475

A07EC01

ATC

sulfasalazine; oral, rectal

2.6

38.2

238

967

Z71.8

ICD-10 Finland

Other specified counselling

1.7

38.0

944

6315

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

3.7

37.9

124

348

WX002

NOMESCO Finland

Sedation and analgesia

1.9

37.8

559

3206

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

37.6

404

2071

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

3.0

37.1

169

582

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

37.1

271

1186

A03FA02

ATC

cisapride; oral, rectal

2.7

37.0

211

820

N05CF01

ATC

zopiclone; oral

1.7

37.0

885

5852

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

36.9

307

1421

NA3BG, ,

SPAT

3.5

36.7

131

389

R03BA05

ATC

fluticasone; inhalant

1.9

36.5

554

3200

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

4.5

36.5

209

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

13.7

36.5

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

36.5

211

826

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

36.5

288

1304

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

36.4

361

1795

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.8

36.2

185

679

H02BX01

ATC

methylprednisolone, combinations; systemic

3.2

36.1

147

474

M24.2

ICD-10 Finland

Disorder of ligament

5.7

36.1

119

D01

ICPC

Abdominal pain/cramps general

2.1

36.1

367

1841

9211

FHL

Exploration or removal of diskusprolapse

361.4

36.0

SPAT1212

SPAT

Extensive examination of musculoskeletal system

2.6

36.0

225

915

M01AC01

ATC

piroxicam; systemic, rectal

2.1

35.8

372

1882

NH3FA

NOMESCO Finland

Weight-bearing X-ray of foot

4.7

35.8

180

M19.8

ICD-10 Finland

Other specified arthrosis

3.4

35.7

130

391

G47.3

ICD-10 Finland

Sleep apnoea

1.8

35.7

638

3876

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.8

35.6

111

301

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.8

35.6

169

NE1BG, ,

SPAT

4.4

35.4

210

R02

ICPC

Shortness of breath/dyspnoea

2.2

35.3

344

1697

P01AB01

ATC

metronidazole; oral, rectal

1.6

34.7

1196

8652

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

34.6

323

1567

M22.4

ICD-10 Finland

Chondromalacia patellae

3.5

34.4

121

356

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

34.4

1218

8865

NH1BG, ,

SPAT

4.6

34.4

186

ZXA10

NOMESCO Finland

Bilateral

1.9

34.1

519

2996

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.1

34.0

146

486

J01CA04

ATC

amoxicillin; systemic

1.8

33.9

2542

22120

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

4.7

33.9

168

ZXE00

NOMESCO Finland

One hour or less

1.6

33.9

1150

8278

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

33.7

206

829

J01FA09

ATC

clarithromycin; systemic

1.6

33.5

949

6527

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

33.5

905

6150

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.1

33.1

369

1913

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

4.0

33.0

239

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

33.0

200

801

SPAT1263

SPAT

Sampling

1.6

32.9

1177

8564

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

5.5

32.9

119

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.1

32.7

347

1766

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

6.9

32.7

N06AB04

ATC

citalopram; systemic

1.8

32.7

604

3697

M65.8

ICD-10 Finland

Other synovitis and tenosynovitis

3.7

32.6

104

287

M43.0

ICD-10 Finland

Spondylolysis

37.8

32.5

7266X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of knee[ENTHESOPATHIA GENUS ALIA DEFINITA SEU NUD]

+∞

32.3

SPAT1260

SPAT

Consultation of another employee

1.9

32.3

474

2700

SPAT1216

SPAT

Assessment of functional ability

2.0

32.3

374

1966

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.0

32.2

367

1918

N06AA10

ATC

nortriptyline; systemic

4.8

32.0

152

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

32.0

459

2595

L84

ICPC

Back syndrome without radiat pain

3.1

31.8

138

462

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

31.8

2060

17106

S76.3

ICD-10 Finland

Injury of muscle and tendon of the posterior muscle group at thigh level

4.8

31.8

153

UJF30

NOMESCO Finland

Ileoscopy through colon

2.1

31.8

312

1542

M77.0

ICD-10 Finland

Medial epicondylitis

3.7

31.7

101

278

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

4.2

31.6

203

L09

ICPC

Arm symptom/complaint

2.8

31.5

159

580

R21

ICPC

Throat symptom/complaint

1.7

31.4

658

4168

R74

ICPC

Upper respiratory infection acute

1.6

31.4

993

6999

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

4.7

31.3

155

R4110, ,

SPAT

2.3

31.3

247

1117

P01BA02

ATC

hydroxychloroquine; oral

2.3

31.0

253

1160

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

30.9

282

1353

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.5

30.8

205

858

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

30.8

160

592

M75.2

ICD-10 Finland

Bicipital tendinitis

3.8

30.6

248

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.7

30.6

174

675

M20.1

ICD-10 Finland

Hallux valgus (acquired)

2.2

30.6

267

1259

XQ800

NOMESCO Finland

Prick test

2.3

30.5

253

1168

N05CF02

ATC

zolpidem; oral

1.8

30.5

517

3079

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

30.4

501

2957

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

6.4

30.3

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

30.3

1095

7946

F45.8

ICD-10 Finland

Other somatoform disorders

2.3

30.3

245

1119

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.3

30.1

242

1102

L04AX03

ATC

methotrexate; systemic

2.1

30.0

291

1430

M76.5

ICD-10 Finland

Patellar tendinitis

6.3

30.0

M25.2

ICD-10 Finland

Flail joint

6.0

29.9

SPAT1310

SPAT

Counselling related to known health issue

1.6

29.8

869

5988

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.9

29.8

385

2100

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.1

29.8

293

1448

J31.0

ICD-10 Finland

Chronic rhinitis

2.2

29.7

265

1260

Z2221

NOMESCO Finland

Medical doctor

1.6

29.7

814

5525

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

3.3

29.7

111

340

N05BA01

ATC

diazepam; systemic, rectal

2.0

29.7

357

1900

SPAT1229

SPAT

Assessment of need for aid

2.5

29.4

190

784

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.3

29.4

237

1080

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

29.4

204

871

7267X

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[ENTHESOPATHIA TARSI ALIA SEU NUD]

+∞

29.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

29.1

385

2115

C07AB07

ATC

bisoprolol; oral

1.5

29.0

1191

8875

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.4

28.9

215

946

M77.8

ICD-10 Finland

Other enthesopathies, not elsewhere classified

7.5

28.9

S89.9

ICD-10 Finland

Unspecified injury of lower leg

3.1

28.8

125

419

ACC51

NOMESCO Finland

Release of median nerve

2.3

28.7

219

975

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.4

28.6

102

303

R05

ICD-10 Finland

Cough

1.7

28.6

604

3825

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.9

28.6

133

464

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

28.5

521

3167

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.3

28.5

111

349

R13

ICD-10 Finland

Dysphagia

2.5

28.2

187

781

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

28.1

324

1697

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.0

28.0

124

420

UKC02

NOMESCO Finland

Cystoscopy

2.0

28.0

346

1856

SFA20

NOMESCO Finland

Two-surface restoration

1.5

28.0

1782

14541

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.5

27.8

180

744

X50

ICD-10 Finland

Overexertion and strenuous or repetitive movements

4.0

27.8

201

R01AD12

ATC

fluticasone furoate; nasal

1.6

27.7

978

7028

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

101.0

27.7

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

27.7

281

1405

M01AB08

ATC

etodolac; oral

2.4

27.6

207

914

D06

ICPC

Abdominal pain localized other

2.1

27.6

262

1276

A02BC04

ATC

rabeprazole; oral

2.1

27.6

267

1310

R03BA02

ATC

budesonide; inhalant

1.8

27.6

516

3155

NG4AA

NOMESCO Finland

Lower leg X-ray examination

3.2

27.6

112

361

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.6

27.4

168

676

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.5

27.4

175

719

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

4.2

27.3

173

G57.6

ICD-10 Finland

Lesion of plantar nerve

4.1

27.1

187

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.9

27.0

405

2315

L11

ICPC

Wrist symptom/complaint

2.1

27.0

281

1417

M20.2

ICD-10 Finland

Hallux rigidus

3.2

27.0

107

340

K59.1

ICD-10 Finland

Functional diarrhoea

2.6

26.9

166

670

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.1

26.9

271

1350

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.4

26.9

200

880

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

26.9

241

1147

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

26.9

140

519

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.8

26.9

130

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

26.8

567

3584

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

26.8

808

5589

9476

FHL

Splitting of fascia or aponeurosis

7.5

26.7

R03BA01

ATC

beclometasone; inhalant

1.9

26.7

387

2189

R51

ICD-10 Finland

Headache

2.5

26.7

178

746

M01AG02

ATC

tolfenamic acid; oral, rectal

1.8

26.7

477

2877

NHK40

NOMESCO Finland

Osteotomy or rotation osteotomy of II-V metatarsal or tarsal bone

4.2

26.7

172

D07AC01

ATC

betamethasone; topical

1.5

26.6

1007

7335

1220

FHL

Arthroscopy

3.0

26.6

117

395

NK1XE

NOMESCO Finland

Other ultrasound examinnation of muscle or tendon

6.2

26.6

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

26.6

367

2043

C07AA05

ATC

propranolol; systemic

1.7

26.6

604

3893

R35

ICD-10 Finland

Polyuria

2.5

26.5

165

669

A11

ICPC

Chest pain NOS

2.3

26.3

217

998

A04

ICPC

Weakness/tiredness general

1.9

26.3

395

2259

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

26.3

1262

9667

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.5

26.3

176

739

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.2

26.2

223

1039

R50.9

ICD-10 Finland

Fever, unspecified

1.8

26.2

413

2398

E0000UV, ,

ATC

1.5

26.1

1207

9169

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.7

26.1

149

579

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

26.1

TAB00

NOMESCO Finland

Lumbar puncture

2.8

26.1

138

516

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

26.0

238

1142

NHL68

NOMESCO Finland

Tenodesis, shortening or lengthening of tendon of foot

5.2

26.0

103

XF402

NOMESCO Finland

ECG with work load test

2.1

26.0

263

1313

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

25.9

202

907

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

3.6

25.9

249

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.1

25.8

109

360

SPAT1312

SPAT

General health counselling

1.6

25.7

880

6261

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

94.2

25.7

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

25.7

149

584

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.7

25.7

593

3835

SFA10

NOMESCO Finland

One-surface restoration

1.5

25.5

1623

13133

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.2

25.5

104

336

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

3.0

25.5

111

373

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

7.6

25.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

25.4

584

3772

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

25.4

311

1663

C03CA01

ATC

furosemide; systemic

1.7

25.3

613

4012

R10.2

ICD-10 Finland

Pelvic and perineal pain

3.6

25.3

229

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

25.3

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

3.6

25.2

234

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.6

25.2

154

619

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.4

25.1

180

779

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

25.1

849

6016

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

5.3

25.1

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

25.0

W19

ICD-10 Finland

Unspecified fall

2.1

25.0

264

1338

M66.4

ICD-10 Finland

Spontaneous rupture of other tendons

9.7

25.0

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

3.2

24.9

101

325

J01EA01

ATC

trimethoprim; systemic

1.6

24.9

719

4910

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.5

24.9

159

653

J01DA09

ATC

[U] cefadroxil

1.6

24.8

770

5349

N06AB10

ATC

escitalopram; oral

1.6

24.8

612

4022

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

24.8

827

5842

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

5.1

24.7

104

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.0

24.5

295

1567

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

24.5

334

1850

M71.2

ICD-10 Finland

Synovial cyst of popliteal space [Baker]

2.9

24.3

113

394

M41.9

ICD-10 Finland

Scoliosis, unspecified

7.9

24.3

R03BA08

ATC

ciclesonide; inhalant

2.0

24.2

260

1325

R4120

NOMESCO Finland

Occupational therapy

2.3

24.2

194

882

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.9

24.2

346

1947

M77.5

ICD-10 Finland

Other enthesopathy of foot

5.5

24.1

A01AB09

ATC

miconazole; local oral

2.1

24.0

234

1150

L20

ICPC

Joint symptom/complaint NOS

2.9

24.0

111

386

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

24.0

S22.3

ICD-10 Finland

Fracture of rib

2.3

23.9

185

828

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.1

23.9

250

1262

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.9

23.9

320

1761

Z00.0

ICD-10 Finland

General medical examination

1.7

23.9

510

3224

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

23.9

271

1410

SPAT1211

SPAT

Application of soft bandage

2.1

23.8

246

1236

M67.4

ICD-10 Finland

Ganglion

2.2

23.8

214

1019

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

23.8

637

4266

C05AA08

ATC

fluocortolone; rectal, topical

1.8

23.8

377

2189

NH3BG

NOMESCO Finland

MRI of foot

7.0

23.7

G04BD12

ATC

mirabegron; oral

2.0

23.7

278

1462

R03AC13

ATC

formoterol; inhalant

2.6

23.7

145

583

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.1

23.7

252

1280

XKD00

NOMESCO Finland

Uroflowmetry

2.0

23.7

292

1563

R06AE09

ATC

levocetirizine; oral

1.7

23.6

452

2773

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

2.7

23.6

128

485

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.6

23.5

695

4765

C10AA07

ATC

rosuvastatin; oral

1.5

23.4

821

5850

SPAT1106

SPAT

Acupuncture

7.9

23.4

G04BD08

ATC

solifenacin; oral

2.4

23.3

169

735

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.2

23.3

146

L10

ICPC

Elbow symptom/complaint

2.4

23.3

170

742

J01MA12

ATC

levofloxacin; systemic

1.7

23.2

468

2912

L90

ICPC

Osteoarthrosis of knee

2.4

23.2

171

750

J20

ICD-10 Finland

Acute bronchitis

2.0

23.1

282

1504

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.0

23.1

105

362

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

23.0

992

7382

M15

ICD-10 Finland

Polyarthrosis

2.6

23.0

131

509

H53.1

ICD-10 Finland

Subjective visual disturbances

2.2

22.9

198

928

R96

ICPC

Asthma

2.0

22.9

255

1318

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.0

22.8

243

1235

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

4.0

22.6

158

NA2BG, ,

SPAT

7.8

22.5

R03AC03

ATC

terbutaline; inhalant

1.8

22.5

396

2370

C10AA05

ATC

atorvastatin; oral

1.5

22.5

994

7426

H57.1

ICD-10 Finland

Ocular pain

2.8

22.5

116

428

J46

ICD-10 Finland

Status asthmaticus

3.4

22.4

238

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.4

22.3

160

693

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

22.3

259

1358

M03BX01

ATC

baclofen; systemic

4.1

22.2

147

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.2

22.2

275

R07.0

ICD-10 Finland

Pain in throat

2.1

22.1

208

1008

M53.2

ICD-10 Finland

Spinal instabilities

52.4

22.1

NCL99

NOMESCO Finland

Other operation on muscle or tendon of elbow or forearm

9.1

22.1

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

35.3

22.0

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

35.3

22.0

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.9

22.0

302

1674

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

22.0

663

4558

N17

ICPC

Vertigo/dizziness

1.9

21.9

305

1698

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

21.9

1096

8382

C09CA06

ATC

candesartan; oral

1.6

21.9

654

4485

R09

ICPC

Sinus symptom/complaint

2.0

21.9

242

1246

M20.4

ICD-10 Finland

Other hammer toe(s) (acquired)

2.6

21.9

125

486

R12

ICD-10 Finland

Heartburn

2.1

21.9

226

1135

J01DA06

ATC

[U] cefuroxime

1.7

21.9

411

2506

S29

ICPC

Skin symptom/complaint other

1.7

21.8

510

3295

R00.2

ICD-10 Finland

Palpitations

2.1

21.8

230

1164

M75

ICD-10 Finland

Shoulder lesions

2.5

21.8

137

558

SPAT1283

SPAT

Restricted health certificate

1.6

21.8

526

3426

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

21.8

510

3297

N03AX09

ATC

lamotrigine; oral

2.4

21.7

147

621

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

21.6

832

6032

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

115.8

21.6

SPAT1240

SPAT

Therapeutic discussion

1.9

21.6

309

1737

D19

ICPC

Teeth/gum symptom/complaint

1.5

21.5

823

5957

K02.1

ICD-10 Finland

Caries of dentine

1.4

21.5

1743

14572

R5110, ,

SPAT

2.3

21.4

167

751

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.8

21.3

105

378

NH1AA, ,

SPAT

3.0

21.3

329

M76.3

ICD-10 Finland

Iliotibial band syndrome

7.9

21.3

NA3AA, ,

SPAT

3.0

21.3

335

NHA30

NOMESCO Finland

Exploration of joint of ankle or foot, arthroscopic

6.8

21.2

H01

ICPC

Ear pain/earache

1.8

21.2

322

1843

NHL99

NOMESCO Finland

Other operation on muscle or tendon of ankle or foot

7.3

21.2

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

3.8

21.2

175

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

5.7

21.2

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

21.1

706

4961

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

21.1

142

598

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

4.5

21.0

115

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

6.3

21.0

R11

ICD-10 Finland

Nausea and vomiting

2.0

21.0

229

1174

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

21.0

269

K10.3

ICD-10 Finland

Alveolitis of jaws

2.4

20.9

147

631

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

20.9

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

20.9

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

20.9

M02AA15

ATC

diclofenac; topical

2.1

20.8

202

991

ZXD20

NOMESCO Finland

Day surgery

1.8

20.8

366

2188

NF1DA

NOMESCO Finland

X-ray of hips

3.9

20.8

159

NHE15

NOMESCO Finland

Suture or reinsertion of ligament of ankle

6.1

20.8

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.9

20.7

155

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

77.3

20.7

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

20.7

631

4343

L05

ICPC

Flank/axilla symptom/complaint

2.3

20.6

162

730

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

20.6

458

2918

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

3.2

20.5

257

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.0

20.3

311

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

20.2

373

2261

C01CA24

ATC

epinephrine; parenteral

2.1

20.2

194

949

F51.0

ICD-10 Finland

Nonorganic insomnia

1.7

20.1

458

2935

G04CA02

ATC

tamsulosin; oral

1.7

20.1

393

2419

S70.0

ICD-10 Finland

Contusion of hip

2.8

20.1

103

379

JAH01

NOMESCO Finland

Laparoscopy

2.4

20.1

136

574

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

4.5

20.1

107

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

20.1

605

4150

RF210, ,

NOMESCO Finland

3.1

20.0

266

C08CA01

ATC

amlodipine; oral

1.5

20.0

893

6654

UJD02

NOMESCO Finland

Gastroscopy

2.5

19.9

124

503

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

2.2

19.9

167

773

J45

ICD-10 Finland

Asthma

1.9

19.9

288

1623

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.9

19.9

272

1506

D02

ICPC

Abdominal pain epigastric

2.2

19.9

170

794

7267B

ICD-9 Finland

Peripheral enthesopathies and allied syndromes, Enthesopathy of ankle and tarsus[TENDINITIS TIBIALIS ANTERIORIS ET POSTERIORIS]

+∞

19.8

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.0

19.7

221

1143

S06.0

ICD-10 Finland

Concussion

1.9

19.7

273

1517

S01

ICPC

Pain/tenderness of skin

2.5

19.7

125

512

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

6.5

19.6

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

19.6

347

2076

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

2.6

19.6

119

477

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

4.5

19.6

105

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

2.3

19.6

155

701

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

19.5

283

1595

M18.1

ICD-10 Finland

Other primary arthrosis of first carpometacarpal joint

3.7

19.5

171

M09AX01

ATC

hyaluronic acid; parenteral

2.6

19.5

110

426

A06AC51

ATC

ispaghula, combinations; oral

2.4

19.4

132

558

WX402

NOMESCO Finland

General anaesthesia

1.6

19.4

577

3942

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

19.4

1000

7652

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

19.3

209

1068

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

5.8

19.3

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

19.3

336

2002

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.8

19.3

313

1827

D11

ICPC

Diarrhoea

1.8

19.3

332

1972

U02

ICPC

Urinary frequency/urgency

1.7

19.2

366

2235

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.4

19.2

135

580

G57.1

ICD-10 Finland

Meralgia paraesthetica

4.1

19.2

128

N05AH04

ATC

quetiapine; oral

1.6

19.2

465

3026

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.6

19.1

116

465

NHM10

NOMESCO Finland

Fasciotomy of ankle or foot

7.2

19.1

N06AB03

ATC

fluoxetine; oral

1.8

19.1

333

1985

NFL20

NOMESCO Finland

Freeing of muscle of hip or thigh

20.2

19.0

NHG77

NOMESCO Finland

Arthroplasty of interphalangeal tarsal joint(s)

3.4

19.0

198

NBE35

NOMESCO Finland

Transposition of ligament of shoulder, arthroscopic

4.8

18.9

L88

ICPC

Rheumatoid/seropositive arthritis

2.6

18.9

112

444

G50.1

ICD-10 Finland

Atypical facial pain

4.0

18.9

134

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.5

18.8

190

WX200

NOMESCO Finland

Interscalenous plexus blockade

3.5

18.7

181

A29

ICPC

General symptom/complaint other

1.8

18.7

303

1768

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

2.5

18.6

121

501

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

6.1

18.6

M01AE52

ATC

naproxen and esomeprazole; oral

2.8

18.5

333

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

191.1

18.5

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

18.5

108

425

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

18.5

369

2283

M19.2

ICD-10 Finland

Other secondary arthrosis

4.5

18.4

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

18.3

201

1032

R06AX22

ATC

ebastine; oral

1.6

18.3

508

3412

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.1

18.3

179

881

KMAK, ,

NOMESCO Finland

1.4

18.3

1490

12322

NE1DG

NOMESCO Finland

Pelvic, hip and femur very extensive MRI examination with high intensity magnet

6.9

18.2

F29

ICPC

Eye symptom/complaint other

1.9

18.1

255

1424

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.2

18.1

235

M01AC02

ATC

tenoxicam; systemic, rectal

2.5

18.1

119

496

N03AF01

ATC

carbamazepine; oral, rectal

2.4

18.1

125

533

M65.3

ICD-10 Finland

Trigger finger

2.3

18.1

136

602

E66.8

ICD-10 Finland

Other obesity

2.1

18.0

165

792

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

831

3646

2.73

122.26

1.4

1.2

9.27

13.59

u/ml

1.07

308

1478

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

837

3865

2.58

109.54

1.5

1.2

31.56

31.01

iu/ml

0.03

255

1264

(3013707) Erythrocyte sedimentation rate by Westergren method

2389

17755

2.41

97.49

5.1

3.5

10.62

11.39

mm/h

2.17

2259

16424

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1042

6155

2.03

70.35

2.4

2.0

200.83

244.74

u/l

0.48

989

5770

(3037522) Nuclear Ab [Titer] in Serum

645

3165

2.30

70.18

1.5

1.3

403.38

586.28

titre

2.08

142

682

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2344

18305

2.08

69.32

7.8

7.2

75.03

77.73

u/l

2.44

2212

17247

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

888

5011

2.07

67.49

2.0

1.7

0.87

1.13

mg/l

2.84

648

3775

(3019198) Lymphocytes [#/volume] in Blood

1722

12260

1.89

65.03

6.4

5.8

1.97

1.93

e9/l

0.40

1558

10917

(3006315) Basophils [#/volume] in Blood

1680

11881

1.88

64.64

6.5

5.8

0.04

e9/l

0.64

1493

10313

(3013115) Eosinophils [#/volume] in Blood

1728

12337

1.88

64.47

6.7

6.1

0.18

0.19

e9/l

0.38

1561

10879

(3001604) Monocytes [#/volume] in Blood

1676

11863

1.88

64.11

6.5

5.8

0.56

e9/l

0.02

1495

10301

(3037467) Urinalysis macro (dipstick) panel - Urine

2129

16313

1.93

63.19

4.8

3.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1552

10856

1.84

60.32

6.3

6.6

1.22

mmol/l

1.18

1346

9201

(40760892) CBC W Ordered Manual Differential panel - Blood

1583

11149

1.84

60.08

6.9

6.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1426

9771

1.84

58.77

5.4

5.9

1.22

1.21

mmol/l

0.94

1295

8919

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

372

1544

2.60

57.81

2.5

2.3

21.74

24.98

au/ml

0.24

156

(3013650) Neutrophils [#/volume] in Blood by Automated count

1860

13872

1.83

57.45

8.4

9.5

3.90

3.98

e9/l

0.89

1648

12120

(3022096) Basophils/100 leukocytes in Blood

1532

10883

1.79

54.67

6.6

6.0

0.69

0.68

0.23

1433

10167

(3031040) Bacteria [#/volume] in Urine by Automated count

1999

15364

1.82

54.54

5.1

3.7

3834.94

1907.06

e6/l

0.40

210

(3019069) Monocytes/100 leukocytes in Blood

1580

11343

1.78

54.24

6.9

6.3

8.37

8.44

0.40

1487

10647

(3006504) Eosinophils/100 leukocytes in Blood

1571

11271

1.78

53.94

6.7

6.0

2.80

2.82

0.20

1473

10562

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

341

1408

2.59

53.40

1.4

1.3

42.87

57.02

au/ml

0.54

(3002030) Lymphocytes/100 leukocytes in Blood

1619

11753

1.77

53.06

6.7

6.0

29.39

28.49

2.81

1526

11070

(3018010) Neutrophils/100 leukocytes in Blood

1593

11562

1.76

51.77

6.5

5.8

56.02

56.90

2.32

1499

10873

(3022217) INR in Platelet poor plasma by Coagulation assay

1383

9680

1.76

50.69

15.1

12.5

1.22

1.21

inr

0.12

398

2922

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2898

25572

2.57

49.66

16.8

11.5

19.56

23.09

mg/l

7.27

2343

19539

(3008898) HLA-B27 [Presence]

213

718

3.11

48.68

1.1

1.0

—

(40768797) Stomach Pathology biopsy report

567

3040

2.05

47.52

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1043

6823

1.79

47.52

2.8

2.4

60.45

60.39

u/l

0.00

962

6303

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1164

7873

1.76

47.17

3.8

3.0

33.56

65.52

ng/l

1.33

695

4776

(36304419) Bacteria [Presence] in Urine

920

5808

1.82

47.14

3.4

2.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1753

13281

1.72

47.03

4.8

4.4

6.44

6.64

mmol/l

4.05

1663

12302

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1142

7702

1.76

46.62

3.6

2.9

—

(3018418) pH of Serum or Plasma

982

6360

1.79

45.98

3.7

4.1

7.40

0.43

172

1249

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1388

9984

1.69

44.16

2.5

2.2

76.37

76.41

nmol/l

0.01

1250

9099

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1259

8823

1.71

44.14

2.1

1.8

99.08

96.80

pmol/l

0.82

610

4515

(3030467) Casts [#/volume] in Urine by Automated count

921

5911

1.79

44.14

3.5

2.8

0.28

0.42

e6/l

2.42

720

4369

(3015171) Extractable nuclear Ab [Units/volume] in Serum

228

854

2.80

43.04

1.2

0.25

1.31

u/ml

1.36

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2373

19809

1.79

42.58

4.5

3.9

14.57

14.63

pmol/l

0.57

2193

18159

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1586

11895

1.67

42.44

5.7

6.3

10.26

11.35

umol/l

5.17

1503

11285

(3024561) Albumin [Mass/volume] in Serum or Plasma

1337

9604

1.68

42.16

4.9

36.51

35.84

g/l

4.81

1239

8955

(3026493) Urate [Moles/volume] in Serum or Plasma

898

5797

1.77

41.78

2.4

2024.01

3898.90

umol/l

1.24

775

5211

(3048689) Calprotectin [Mass/mass] in Stool

529

2891

2.00

41.57

2.1

2.3

106.45

124.53

ug/g

0.68

419

2316

(3018095) Leukocytes [#/volume] in Urine

1134

7851

1.69

40.75

4.0

3.3

79.01

111.97

e6/l

0.93

827

5302

(3009261) Glucose [Presence] in Urine by Test strip

1543

11605

1.64

39.93

3.9

3.2

0.00

0.01

estimate

0.25

299

2059

(3002582) Erythrocytes [#/volume] in Urine

977

6526

1.72

39.91

3.5

2.9

128.45

96.01

e6/l

0.15

767

4902

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1475

11050

1.63

38.17

2.6

2.4

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

849

5528

1.73

37.65

1.4

1.3

0.86

2.03

u/ml

5.73

219

1476

(3021601) Nitrite [Presence] in Urine by Test strip

1520

11505

1.62

37.46

5.3

4.4

0.00

estimate

0.50

305

2127

(3035350) Ketones [Presence] in Urine by Test strip

1516

11480

1.62

37.20

3.9

3.2

0.00

estimate

1.23

316

2238

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

597

3521

1.86

36.91

2.9

2.5

1.14

1.26

e6/l

0.23

331

1903

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2687

23680

1.89

35.58

5.5

4.5

1.77

2.18

mu/l

2.45

2513

21868

(3019550) Sodium [Moles/volume] in Serum or Plasma

2875

25957

2.17

35.20

17.6

12.9

139.70

139.72

mmol/l

0.12

2834

25230

(3007164) IgA [Mass/volume] in Serum or Plasma

761

4885

1.73

35.15

1.5

1.4

2.20

2.33

g/l

1.30

427

3065

(3015736) pH of Urine

1261

9298

1.59

33.45

3.5

2.9

5.81

5.85

0.18

105

902

(3023103) Potassium [Moles/volume] in Serum or Plasma

2876

26062

2.13

33.36

17.8

13.0

3.96

3.95

mmol/l

0.89

2830

25263

(3044889) 12 lead EKG panel

2057

17015

1.60

32.89

3.9

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

691

4403

1.73

32.42

2.8

2.4

5.51

6.96

e6/l

2.17

633

3935

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

632

3948

1.75

31.75

4.5

3.2

331.33

463.66

ng/l

0.45

438

2833

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1431

10976

1.55

31.29

3.2

2.7

100.25

113.34

ug/l

1.58

1323

10249

(3026782) Osmolality of Urine

666

4247

1.72

31.00

3.0

2.6

522.20

537.65

mosm/kgh2o

0.99

585

3644

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

792

5295

1.66

30.83

2.9

837.76

1333.17

ng/l

4.91

656

4483

(3044640) Blood type and Crossmatch panel - Blood

1028

7376

1.58

29.77

2.4

2.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

546

3350

1.76

28.95

3.1

2.6

4.35

3.01

e6/l

1.31

286

1738

(3036481) Cortisol [Moles/volume] in Serum or Plasma

376

2066

1.93

28.41

2.2

369.58

381.10

nmol/l

0.54

345

1914

(40758558) Short blood count panel - Blood

871

6074

1.60

28.17

6.1

7.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2132

18113

1.54

27.40

3.6

3.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

172

703

2.53

27.19

1.6

1.8

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

788

5416

1.61

26.88

2.4

2.1

2.84

2.91

mg/l

0.28

680

4605

(3021589) Normoblasts [#/volume] in Blood

1393

10877

1.50

26.51

10.3

8.8

0.00

e9/l

0.46

1150

8862

(3033658) Prothrombin time (PT) actual/Normal

842

5903

1.58

26.32

4.6

3.8

92.40

93.01

0.29

829

5771

(3021960) Folate [Moles/volume] in Serum or Plasma

702

4715

1.63

26.23

1.7

1.5

19.65

20.92

nmol/l

1.78

616

4044

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2091

17790

1.52

25.82

3.5

2.8

46.15

44.26

u/l

0.46

1961

16729

(3007853) Bacteria identified in Skin by Aerobe culture

431

2557

1.79

25.40

1.9

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

378

2163

1.85

25.06

2.7

2.3

29.50

62.41

u/l

0.89

323

1893

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2698

24436

1.70

24.47

14.2

10.9

84.87

84.73

ml/min/173m2

0.13

2339

19936

(3015377) Calcium [Moles/volume] in Serum or Plasma

1040

7744

1.51

24.34

3.0

3.5

2.36

2.35

mmol/l

0.48

909

6938

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

793

5578

1.56

24.08

2.3

2.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

281

1484

1.98

23.71

1.4

1.3

112.61

236.95

u/ml

4.27

267

1375

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

288

1538

1.96

23.53

3.0

4.1

73.85

86.80

ng/l

2.64

252

1341

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2954

27580

2.06

23.15

18.1

13.2

74.37

73.89

umol/l

0.44

2954

27574

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2562

23018

1.59

22.66

5.8

5.0

39.11

39.10

mmol/mol

0.01

2398

21437

(3023368) Bacteria identified in Blood by Culture

782

5548

1.54

22.64

4.5

4.2

—

(40761511) CBC panel - Blood by Automated count

2922

27225

1.95

22.32

15.0

10.8

—

(3022145) Colonoscopy Study observation

415

2535

1.73

21.93

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

138

564

2.51

21.83

1.4

284.85

288.41

ug/g

0.06

316

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2965

27801

2.05

21.67

11.8

9.1

26.48

26.32

u/l

0.22

2883

26850

(3026008) Bacteria identified in Urine by Culture

895

6588

1.50

21.61

3.3

2.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

721

5075

1.54

21.47

3.6

3.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

723

5094

1.54

21.43

1.7

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

170

778

2.25

20.86

2.0

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

153

678

2.32

20.26

1.5

1.7

0.24

g/l

0.08

146

643

(3019309) Folate [Moles/volume] in Red Blood Cells

543

3625

1.60

20.24

1.8

1.7

1174.14

1133.01

nmol/l

0.50

415

2759

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1140

8914

1.44

19.75

4.1

3.2

—

(3000494) Fungus identified in Specimen by Culture

428

2713

1.67

19.60

1.5

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

156

708

2.27

19.54

1.5

1.7

1.22

1.19

g/l

0.82

149

673

(40768804) Tissue Pathology biopsy report

1293

10359

1.42

19.50

2.2

2.0

—

(3042936) Bacteria identified in Isolate by Culture

464

3010

1.63

19.39

2.2

2.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

110

429

2.62

19.19

1.6

4927.65

14859.69

e6/l

3.19

313

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2690

24684

1.60

19.18

4.8

4.0

5.88

5.83

mmol/l

0.90

2501

22703

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

578

3964

1.56

19.08

2.6

3.0

2.44

2.45

mmol/l

0.93

489

3499

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

263

1461

1.87

19.00

1.8

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

419

2681

1.65

18.44

2.6

2.8

5.29

8.14

umol/l

6.31

362

2330

(3000492) Spirometry study

396

2510

1.66

18.06

1.4

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

145

660

2.25

18.04

1.2

31.80

45.47

u/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

265

1501

1.84

17.99

2.1

2.7

66.46

66.48

g/l

0.01

242

1383

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

136

606

2.30

17.80

1.2

3.19

10.09

u/ml

1.44

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

134

603

2.28

17.15

1.2

5.33

3.40

u/ml

0.19

(3002385) Erythrocyte distribution width [Ratio]

2474

22475

1.46

16.70

19.2

14.3

14.79

14.64

0.60

2450

22043

(3004588) Protein electrophoresis panel - Serum or Plasma

222

1221

1.88

16.53

1.7

2.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

492

3357

1.55

16.42

2.4

13.52

13.61

umol/l

0.11

461

3143

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

479

3249

1.56

16.41

1.9

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

232

1302

1.84

16.21

1.0

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1037

8197

1.39

16.06

3.5

3.2

29.83

34.88

u/l

1.65

978

7810

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

186

975

1.96

15.99

1.9

2.0

40.79

38.82

u/l

0.68

171

887

(3013512) EKG study

842

6424

1.42

15.99

4.0

3.4

—

(36660697) Celiac disease serology panel - Serum

319

1974

1.69

15.88

1.2

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

457

3096

1.56

15.70

2.4

2.41

2.35

g/l

1.62

419

2870

(3021788) Differential panel - Synovial fluid

317

2.69

15.69

1.6

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

4.37

15.67

1.1

1.7

4.63

6.01

u/l

1.53

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

344

2184

1.65

15.50

1.8

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

779

5894

1.43

15.40

4.4

3.4

0.00

estimate

1.54

300

2069

(3014765) Yersinia sp identified in Stool by Organism specific culture

132

631

2.14

14.60

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

3058

29401

2.18

14.56

24.1

17.1

40.49

40.50

0.02

2913

27767

(3024731) MCV [Entitic volume]

3062

29455

2.20

14.54

23.9

17.0

90.82

90.60

2.10

3037

29034

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

338

2170

1.62

14.54

1.7

—

(3035941) MCH [Entitic mass]

3062

29456

2.20

14.53

23.8

17.0

30.28

30.20

1.87

3037

29032

(3007461) Platelets [#/volume] in Blood

3060

29434

2.18

14.44

24.0

17.1

259.46

256.37

e9/l

1.89

3017

28661

(3010813) Leukocytes [#/volume] in Blood

3062

29462

2.20

14.42

24.0

17.1

6.66

6.59

e9/l

0.87

3012

28605

(3026361) Erythrocytes [#/volume] in Blood

3062

29462

2.20

14.42

24.0

17.0

4.51

4.52

e12/l

1.00

3011

28616

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

182

3.17

14.38

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

107

473

2.31

14.32

1.2

1.08

1.50

u/ml

—

(3000963) Hemoglobin [Mass/volume] in Blood

3062

29471

2.19

14.25

24.0

17.1

135.95

135.90

g/l

0.07

3037

29043

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

180

3.15

13.99

1.2

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

132

642

2.10

13.97

2.4

3.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

131

636

2.11

13.93

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

841

6545

1.39

13.89

3.7

2.9

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

140

699

2.05

13.82

1.3

—

(3019150) Specific gravity of Urine by Refractometry

634

4702

1.44

13.80

4.3

3.4

1.02

kg/l

0.35

701

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

145

734

2.02

13.78

1.6

620.00

497.86

titre

—

(4200892) Spirometry reversibility

247

1494

1.71

13.35

1.5

1.4

—

(3025941) Bacteria identified in Stool by Culture

225

1326

1.75

13.34

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

180

3.09

13.34

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

180

3.09

13.34

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

128

627

2.09

13.31

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

181

3.07

13.22

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

181

3.07

13.22

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

109

503

2.21

13.19

1.2

45.97

37.84

u/ml

0.14

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2781

26146

1.52

13.17

5.2

4.3

2.83

2.87

mmol/l

1.75

2594

24368

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

249

1515

1.70

13.17

2.3

2.1

7.78

7.83

ug/l

0.01

206

1341

(3009508) Creatinine [Moles/volume] in Urine

882

6968

1.37

13.16

3.2

3.3

7.71

7.61

mmol/l

0.25

744

5959

(3012095) Magnesium [Moles/volume] in Serum or Plasma

497

3555

1.47

13.03

3.4

3.7

0.81

0.82

mmol/l

0.64

469

3350

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

416

2870

1.52

13.02

2.5

23.09

23.50

0.24

356

2497

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2744

25788

1.48

12.38

4.7

4.0

4.74

4.80

mmol/l

2.41

2582

24188

(3004616) Nuclear Ab [Presence] in Serum

279

2.58

12.31

1.5

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

245

1518

1.67

12.10

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

103

482

2.18

12.07

1.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2726

25624

1.46

11.91

4.7

4.0

1.47

1.50

mmol/l

3.79

2546

23919

(3004716) Salmonella sp identified in Stool by Organism specific culture

219

1324

1.70

11.86

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

101

475

2.16

11.70

1.2

—

18.60

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

114

567

2.05

11.42

1.8

2.1

38.63

37.64

g/l

0.86

105

507

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

125

643

1.98

11.41

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

326

2195

1.54

11.37

6.1

8.1

5.03

5.09

kpa

0.68

313

2104

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2642

24745

1.41

11.29

4.2

3.6

1.32

1.28

mmol/l

2.15

2445

22937

(3003458) Phosphate [Moles/volume] in Serum or Plasma

396

2783

1.48

11.26

5.3

6.4

1.02

1.04

mmol/l

0.48

361

2600

(3027801) Oxygen [Partial pressure] in Arterial blood

325

2194

1.54

11.20

6.1

8.0

12.55

12.85

kpa

0.51

313

2103

(3005719) IgG [Mass/volume] in Serum or Plasma

274

1780

1.59

11.18

2.9

2.7

10.47

10.56

g/l

0.13

251

1636

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

106

518

2.08

11.14

1.8

2.2

0.00

g/l

-0.00

476

(3025159) Blasts/100 leukocytes in Blood

259

1662

1.61

11.12

4.2

4.4

0.15

0.67

0.91

436

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

110

547

2.05

11.04

1.8

2.2

0.01

g/l

0.06

101

502

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

127

666

1.94

10.98

1.9

2.2

2.92

2.99

g/l

0.31

116

607

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

807

6448

1.34

10.82

1.7

1.6

1.41

1.39

mmol/l

0.17

686

5458

(3021440) Promyelocytes/100 leukocytes in Blood

269

1755

1.58

10.78

4.2

4.4

0.18

0.11

0.26

529

(3003396) Base excess in Arterial blood by calculation

324

2204

1.52

10.77

6.3

8.0

0.71

1.11

mmol/l

1.05

254

1770

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

708

1.90

10.68

1.8

2.2

3.51

3.70

g/l

1.23

121

650

(3002179) Metamyelocytes/100 leukocytes in Blood

260

1688

1.59

10.64

4.0

4.1

0.54

0.67

0.54

530

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

709

1.90

10.63

1.8

2.2

7.14

7.32

g/l

0.58

121

649

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

132

709

1.90

10.63

1.8

2.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

126

669

1.92

10.51

1.7

2.2

9.56

10.34

g/l

1.49

115

606

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

121

634

1.94

10.50

2.2

2.1

10.94

11.45

mg/l

0.24

113

596

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

128

684

1.91

10.48

1.1

7.37

6.09

u/ml

0.09

102

(3018677) aPTT in Platelet poor plasma by Coagulation assay

450

3284

1.43

10.47

2.2

2.1

29.75

29.58

0.22

434

3183

(3017181) Myelocytes/100 leukocytes in Blood

278

1842

1.56

10.41

4.2

4.3

1.06

0.96

0.12

612

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

103

513

2.04

10.31

1.8

2.2

0.00

g/l

-0.00

475

(3044941) Cell count panel - Synovial fluid

292

2.39

10.29

1.6

1.4

—

(3016502) Oxygen saturation in Arterial blood

290

1947

1.54

10.24

6.5

8.6

96.50

96.04

0.91

281

1883

(40761535) Cells panel - Urine sediment

242

1559

1.60

10.23

3.9

3.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

317

2173

1.51

10.16

2.3

2.9

1.75

0.03

285

1934

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

125

672

1.90

10.06

2.3

374.61

917.57

ug/l

0.90

116

634

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

116

610

1.94

9.97

1.9

2.3

0.45

0.98

g/l

1.44

103

531

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

472

2.07

9.97

1.3

1.4

3.69

3.75

mmol/l

0.19

445

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

241

1563

1.59

9.91

3.0

2.7

129.75

177.99

ng/l

2.18

214

1398

(3012516) Albumin [Mass/volume] in Urine

786

6324

1.32

9.91

3.3

361.51

321.25

mg/l

0.09

492

3991

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

189

1154

1.68

9.89

1.7

1.6

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

106

546

1.97

9.69

1.3

1.4

484.48

503.39

mg/l

0.22

521

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

264

2.41

9.62

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

395

2.13

9.40

1.1

6.30

3.49

u/ml

0.33

209

(40768443) Skin Pathology biopsy report

165

988

1.71

9.30

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

357

2553

1.45

9.23

6.5

5.6

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

198

2.60

9.15

1.6

1.7

58.39

58.30

0.00

133

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

474

2.01

9.14

1.3

1.6

371.74

1088.64

e6/l

0.81

385

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

475

2.01

9.09

1.2

1.5

13.46

21.26

e6/l

0.34

364

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

165

2.75

9.02

1.1

1.2

1.08

1.51

u/ml

0.20

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

247

1651

1.54

8.90

3.1

3.4

4.46

4.52

pmol/l

0.50

219

1487

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

323

2287

1.46

8.79

3.5

4.5

232.22

245.29

u/l

1.19

305

2175

(3014111) Lactate [Moles/volume] in Serum or Plasma

254

1715

1.52

8.74

6.5

7.6

1.27

1.32

mmol/l

0.41

248

1673

(3002032) Base excess in Venous blood by calculation

264

1799

1.51

8.70

5.0

4.0

1.61

1.83

mmol/l

0.53

234

1505

(3024980) IgG subclass 4 [Mass/volume] in Serum

376

2.10

8.58

1.4

1.7

0.66

0.83

g/l

0.89

294

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

122

690

1.80

8.41

1.5

1.6

0.01

0.46

iu/ml

1.17

135

(1002224) Polysomnography panel

190

1213

1.60

8.37

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

262

1804

1.49

8.21

5.1

4.0

5.86

5.81

kpa

0.43

254

1744

(3017446) Testosterone [Moles/volume] in Serum or Plasma

225

1501

1.54

8.19

2.3

2.1

13.45

12.91

nmol/l

0.48

202

1385

(3019060) Gas panel - Arterial blood

188

1204

1.60

8.18

4.2

5.4

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

247

2.33

8.14

1.2

1.3

—

nmol/l

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

124

2.93

8.12

1.2

1.1

2.16

8.44

nmol/l

—

(3028026) IgM [Mass/volume] in Serum or Plasma

212

1399

1.55

8.11

1.8

1.9

1.21

1.45

g/l

1.63

193

1284

(3023420) DNA double strand Ab [Units/volume] in Serum

246

2.30

7.76

1.5

1.6

22.17

29.20

iu/ml

—

(3024263) Appearance of Synovial fluid

102

3.06

7.58

1.1

1.4

—

(4094501) Cardiovascular stress test using bicycle ergometer

115

661

1.77

7.55

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

226

1538

1.51

7.51

2.9

2.8

72.90

70.73

e9/l

0.36

173

1151

(3020682) Albumin/Creatinine [Ratio] in Urine

802

6674

1.27

7.50

3.8

3.9

5.34

9.07

mg/mmol

3.11

489

4238

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

119

2.88

7.47

1.1

1.01

1.10

u/l

0.54

(3000991) Gas panel - Venous blood

240

1659

1.48

7.39

6.4

9.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

164

1044

1.60

7.34

6.6

10.3

24.05

24.41

mmol/l

0.71

158

1019

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

456

1.91

7.31

1.7

1.8

224.43

207.69

pmol/l

0.58

435

(3017143) Hepatitis C virus Ab [Presence] in Serum

403

3065

1.36

7.25

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

167

1073

1.59

7.20

2.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

422

3245

1.35

7.06

2.2

2.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

145

905

1.63

7.05

1.6

1.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.62

7.02

1.5

85.77

113.73

nmol/24h

0.63

(3019420) Tryptase [Mass/volume] in Serum or Plasma

129

2.73

7.02

1.4

1.6

5.58

9.09

ug/l

1.59

113

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

386

1.97

6.97

1.1

17.96

10.81

au/ml

—

(3019225) pH of Specimen

301

2199

1.41

6.91

3.7

4.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

172

1127

1.56

6.83

1.5

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

584

4729

1.29

6.72

1.6

12971149.46

33599040.64

pmol/l

0.72

478

4021

(3028707) Methadone [Presence] in Urine by Screen method

457

1.86

6.64

2.5

2.9

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

379

2894

1.35

6.63

2.1

1.9

—

(3017732) Neutrophils [#/volume] in Blood

238

1680

1.45

6.60

2.1

2.9

4.67

4.51

e9/l

0.09

200

1434

(44813793) Dust mix specific IgE antibody measurement

158

2.49

6.51

1.2

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

211

1464

1.47

6.41

4.1

3.2

4.59

4.67

kpa

0.23

203

1412

(3044290) Cell count panel - Cerebral spinal fluid

470

1.83

6.39

1.2

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

137

865

1.61

6.39

2.5

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

250

1793

1.43

6.37

2.9

3.6

1.23

mmol/l

0.12

219

1555

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

2.66

6.15

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

170

2.37

6.05

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

343

1.94

6.02

1.2

—

(3045414) Leukocytes [Presence] in Urine

146

951

1.56

5.98

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

7.25

5.92

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

2.96

5.84

1.2

1.0

—

(3011288) Drugs identified in Urine by Screen method

121

760

1.62

5.79

2.7

2.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

172

1172

1.49

5.74

3.7

3.5

1.53

1.71

mmol/l

0.26

129

885

(3010838) Calcium [Moles/time] in 24 hour Urine

421

1.83

5.72

1.9

5.50

5.34

mmol/24h

0.16

372

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

213

2.18

5.72

2.5

2.2

15.75

20.17

mg/l

0.47

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

138

2.48

5.69

1.5

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

138

2.48

5.69

1.5

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

533

1.73

5.68

2.3

3.3

33.09

55.22

mg/l

0.73

427

(3014051) Protein [Presence] in Urine by Test strip

513

1.74

5.59

2.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

368

2869

1.32

5.59

1.7

—

(3049717) Cytology report of Urine Cyto stain

108

666

1.64

5.58

2.2

2.4

—

(3011985) Renin [Units/volume] in Plasma

277

2.00

5.51

1.4

1.5

38.49

53.51

mu/l

0.50

244

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

165

2.32

5.51

1.1

—

(3022621) pH of Urine by Test strip

200

1418

1.44

5.46

3.0

2.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

450

1.77

5.45

3.7

3.4

58.57

56.63

0.79

450

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

377

1.85

5.45

2.1

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

155

1046

1.51

5.44

2.0

2.2

5167.01

5595.11

u/l

0.05

432

(3028300) Cannabinoids [Presence] in Urine

167

1145

1.48

5.42

2.7

2.1

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

533

1.71

5.42

2.4

3.3

30.05

61.43

mg/l

1.85

423

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

410

3265

1.29

5.32

1.7

1.43

1.39

0.63

353

2938

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

637

5348

1.24

5.30

4.6

4.2

2.65

2.30

ug/l

0.26

573

4818

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

288

2185

1.35

5.27

2.6

2.2

0.23

0.22

g/l

2.07

268

2057

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

609

1.65

5.19

1.9

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

109

2.58

5.13

1.4

1.3

127.50

129.26

nmol/l

0.09

109

(3027008) Opiates [Presence] in Urine

165

1143

1.47

5.11

2.6

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

164

1135

1.47

5.10

2.6

2.1

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

176

1235

1.45

5.10

3.9

3.5

5.13

5.14

kpa

0.08

169

1180

(3009343) pH of Capillary blood

174

1220

1.45

5.06

3.8

3.5

7.42

0.14

151

(3027944) Amphetamines [Presence] in Urine

162

1124

1.47

4.98

2.6

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

250

1874

1.36

4.95

2.0

1.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

167

2.23

4.94

1.4

48071.30

84728.58

e6/l

0.24

114

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

297

2289

1.33

4.90

3.5

3.0

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

221

2.05

4.87

1.2

1.4

0.47

0.43

g/l

0.29

159

(3026389) Candida sp identified in Specimen by Organism specific culture

312

1.88

4.84

1.4

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

222

2.04

4.81

1.2

1.4

6.70

6.90

g/l

0.14

157

(3028192) IgG subclass 2 [Mass/volume] in Serum

222

2.04

4.81

1.2

1.4

3.39

2.93

g/l

0.72

161

(3016879) Cocaine [Presence] in Urine

151

1042

1.47

4.78

2.7

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

322

1.85

4.72

1.4

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

250

1891

1.35

4.68

1.2

136.67

155.56

iu/ml

0.27

723

(3006184) Hemoglobin [Mass/volume] in Capillary blood

434

1.72

4.66

2.4

2.1

134.17

130.65

g/l

0.60

318

(46235355) HIV 1 and 2 tests - Meaningful Use set

599

5062

1.23

4.64

1.8

1.9

—

(4062490) Immunoglobulin typing, IgG

220

2.01

4.56

1.2

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

2.87

4.49

1.1

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

350

1.79

4.47

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

372

2998

1.27

4.40

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

244

1.94

4.39

1.1

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

199

1468

1.38

4.38

1.8

1.7

—

(3036180) Methadone [Presence] in Urine

112

2.42

4.38

2.2

1.9

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

137

2.28

4.38

1.7

1.6

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.52

4.35

1.1

—

(3024928) Oxygen saturation in Venous blood

428

1.70

4.35

5.5

3.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.60

4.30

2.1

1.8

141.27

117.83

umol/l

0.15

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

430

1.69

4.28

1.2

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

430

1.69

4.28

1.2

1.3

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

109

723

1.53

4.22

1.8

1.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

159

2.15

4.21

1.5

1.4

23.47

32.79

0.77

101

(3038026) Centromere Ab [Units/volume] in Serum

179

2.08

4.21

1.4

1.2

—

61.53

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

550

1.60

4.16

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

411

1.69

4.15

2.9

2.4

17.25

16.51

0.81

199

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

180

2.07

4.15

3.9

4.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

340

1.75

4.00

1.1

1.44

1.48

g/l

0.43

307

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

122

839

1.47

3.99

1.2

1.3

—

(3003338) MCHC [Mass/volume]

2388

22854

1.18

3.97

20.5

14.6

332.82

332.50

g/l

0.99

2379

22671

(3003888) Timothy IgE Ab [Units/volume] in Serum

494

1.61

3.96

1.1

4.08

5.41

u/ml

0.48

242

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

394

1.69

3.96

1.2

3.42

3.80

u/ml

0.16

178

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.08

3.90

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

258

2017

1.30

3.88

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

537

1.58

3.86

1.3

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

160

1165

1.39

3.85

5.8

3.2

130.12

128.69

g/l

0.34

155

1132

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.97

3.84

1.6

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

225

1730

1.32

3.82

2.4

75.49

68.19

ml/min/173m2

2.09

637

(3020779) Urea [Moles/volume] in Serum or Plasma

243

1891

1.31

3.79

7.6

8.1

9.01

9.14

mmol/l

0.13

232

1803

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

548

1.57

3.77

1.1

1.36

1.98

u/ml

0.43

253

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.70

3.65

1.5

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

190

1.96

3.62

1.1

1.0

—

(40761536) Microorganisms panel - Urine sediment

257

2029

1.29

3.61

4.5

3.4

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

184

1.97

3.58

1.5

1.4

1.33

1.15

promille

0.31

141

(3035320) C reactive protein [Mass/volume] in Body fluid

157

2.05

3.55

3.2

2.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

355

2921

1.24

3.53

4.7

4.1

32.47

32.32

0.09

254

2034

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

138

2.11

3.49

1.1

—

(3023410) Appearance of Cerebral spinal fluid

222

1.86

3.45

1.3

1.8

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

237

1.83

3.43

1.2

64.05

66.54

u/l

0.06

216

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

559

4830

1.19

3.39

1.5

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

190

1457

1.32

3.32

1.4

1.3

26.32

30.32

iu/l

1.02

166

1258

(3036489) Thrombin time

126

907

1.41

3.29

2.1

2.0

22.07

21.30

0.38

110

784

(3000330) Specific gravity of Urine by Test strip

141

1035

1.38

3.28

3.5

3.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

110

773

1.44

3.28

4.3

3.7

24.94

24.79

mmol/l

0.21

101

718

(3008401) Mugwort IgE Ab [Units/volume] in Serum

472

1.56

3.25

1.1

0.90

1.43

u/ml

0.47

190

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

163

1.97

3.24

1.1

—

(3003181) Sodium [Moles/volume] in Urine

317

1.68

3.22

1.4

61.91

64.40

mmol/l

0.17

257

(3020891) Body temperature

104

726

1.45

3.21

3.8

4.5

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

144

1066

1.37

3.19

8.7

11.0

—

(3012501) Base excess in Blood by calculation

468

1.55

3.14

4.2

3.8

1.99

2.64

mmol/l

1.75

316

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.96

3.13

1.2

1.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

345

1.63

3.06

1.3

7.31

7.27

mmol/l

0.03

308

(3028271) Lactate [Moles/volume] in Capillary blood

322

1.66

3.05

2.0

1.8

1.52

1.63

mmol/l

0.68

314

(3010421) pH of Blood

553

1.50

3.03

3.9

3.8

7.42

0.09

507

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

652

1.46

3.02

3.3

3.0

0.31

0.34

u/ml

0.75

368

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

371

1.60

2.98

1.4

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

148

1.97

2.94

1.7

1.6

2.29

7.25

u/l

3.27

126

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

147

1107

1.34

2.94

1.7

1.6

3.81

4.34

mg/l

0.31

112

794

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

122

893

1.38

2.92

1.3

176.05

225.31

miu/ml

0.89

438

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

405

1.57

2.91

1.2

2.00

2.73

u/ml

0.44

144

(3002256) Pathology report gross observation

386

3271

1.21

2.90

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

259

1.71

2.87

1.7

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

352

1.60

2.85

1.2

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

157

1.92

2.84

3.7

2.1

—

(3022313) Gas panel - Capillary blood

122

898

1.37

2.83

4.1

3.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

695

1.42

2.82

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

314

1.63

2.82

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

704

1.42

2.81

1.3

370.00

1041.36

titre

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.47

2.78

1.0

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

2.32

2.74

5.2

2.2

10.22

8.58

0.16

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

558

1.46

2.73

1.3

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

3.01

2.69

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

175

1.84

2.68

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

175

1.84

2.68

1.3

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

220

1.74

2.64

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

176

1.83

2.63

1.1

1.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.26

2.60

1.3

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

134

1.95

2.60

1.7

1.4

18.96

23.92

umol/l

0.55

128

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

100

2.11

2.58

1.1

—

(3042517) Benzodiazepines panel - Urine

4.01

2.56

3.6

2.8

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.46

2.54

1.2

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

118

881

1.35

2.54

1.6

1.8

1.64

1.56

g/l

0.35

757

(3010726) Horse dander IgE Ab [Units/volume] in Serum

460

1.49

2.53

1.1

1.16

1.48

u/ml

0.17

210

(3002523) Influenza virus A Ag [Presence] in Specimen

493

1.47

2.53

1.1

—

(3021901) Oxygen saturation in Capillary blood

340

1.57

2.51

3.0

2.9

—

(40760888) Immunoglobulin light chains.free panel - Serum

405

1.52

2.49

2.0

3.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

2.98

2.48

1.2

1.9

—

246.33

—

(3003740) Influenza virus B Ag [Presence] in Specimen

495

1.47

2.48

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.13

2.43

1.3

1.4

—

(3007463) Buprenorphine [Presence] in Urine

5.01

2.40

15.2

3.3

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.34

2.39

1.0

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.34

2.39

1.0

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

702

1.38

2.37

1.5

1.4

10.32

10.75

u/l

0.12

578

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

139

1.88

2.36

2.7

2.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.83

2.34

1.3

2.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

479

4216

1.16

2.32

1.6

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

129

993

1.31

2.29

1.6

1.7

256.98

309.77

mu/l

2.55

121

897

(3008757) Leukocyte morphology finding [Identifier] in Blood

215

1.68

2.28

1.9

4.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

333

1.54

2.27

1.5

1.8

—

(3008295) Osmolality of Serum or Plasma

216

1.67

2.25

1.3

1.5

277.00

282.73

mosm/kgh2o

0.75

177

(3017354) Segmented neutrophils/100 leukocytes in Blood

186

1.73

2.24

2.1

3.4

63.77

55.84

1.32

162

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

370

3202

1.18

2.23

2.8

2.7

0.64

0.73

ug/l

1.53

221

1928

(3023183) Ammonium ion [Moles/volume] in Plasma

460

1.44

2.16

2.7

3.0

34.97

37.89

umol/l

0.35

430

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

219

1.65

2.15

1.3

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

227

1.64

2.14

1.1

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.62

2.14

1.0

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

708

1.35

2.12

1.3

80.67

130.00

titre

0.51

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

130

1.85

2.12

1.3

—

301.67

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

220

1.64

2.12

1.1

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

2.05

2.11

1.8

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

117

901

1.31

2.10

2.1

1.9

—

(3028433) Virus identified in Specimen by Culture

2.14

2.08

1.5

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

169

1.72

2.03

1.2

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

286

1.55

2.03

1.7

1.6

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

478

4250

1.15

2.02

4.0

3.6

21.63

0.00

205

1839

(3028626) Oxygen [Partial pressure] in Capillary blood

426

1.44

2.00

2.9

3.1

8.71

8.31

kpa

1.14

415

(3002619) Bacteria identified in Specimen by Culture

2.64

2.00

1.2

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

2.82

2.00

1.0

1.1

—

(3037121) Protein [Mass/volume] in Urine

752

1.33

1.97

2.9

3.6

0.33

0.37

g/l

0.14

325

(4146454) Self-monitoring of blood glucose

217

1.62

1.97

2.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

106

815

1.31

1.94

2.0

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.45

1.93

1.5

1.2

38.33

39.28

g/l

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

157

1.73

1.92

1.1

1.05

ratio

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

109

1394

0.77

1.89

1.4

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.65

1.86

1.2

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

2.65

1.86

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.86

1.86

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

100

1.91

1.85

1.1

1.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.40

1.85

2.1

1.3

—

(3023419) Bacteria identified in Sputum by Culture

277

1.52

1.84

3.9

2.6

—

(3047181) Lactate [Moles/volume] in Blood

630

1.34

1.84

6.0

6.7

1.19

1.31

mmol/l

0.86

547

(3004809) Band form neutrophils/100 leukocytes in Blood

326

1.48

1.83

2.7

3.5

0.90

1.55

1.45

297

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

460

1.40

1.82

1.6

1.4

—

(1616796) Gas panel - Central venous blood

435

1.41

1.81

4.4

3.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

145

1.73

1.81

1.0

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

462

1.39

1.78

2.6

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.90

1.75

1.2

143.17

161.31

mmol/24h

0.53

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

120

955

1.27

1.72

1.4

1.5

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.67

1.72

1.5

1.6

0.29

0.15

nmol/l

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

3.85

1.71

2.0

2.1

4.60

3.12

mg/l

—

(3051611) Lipemic interference index of Serum or Plasma

226

1.55

1.70

2.2

3.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

179

1.63

1.69

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.16

1.66

1.0

1.2

1.54

1.88

umol/24h

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.86

1.66

1.3

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

188

1.60

1.66

1.2

1.4

1.78

2.10

mmol/l

1.79

180

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

2.03

1.64

1.0

1.2

—

29.88

—

(3020491) Glucose [Moles/volume] in Blood

173

1.62

1.63

1.6

1.9

6.06

6.65

mmol/l

0.95

114

(3030313) Adrenal Ab [Titer] in Serum

3.58

1.61

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

1.84

1.61

1.2

1.5

2.04

3.43

nmol/l

0.47

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.50

1.59

2.0

1.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

544

0.68

1.59

5.0

3.2

22.32

25.85

mg/l

0.28

337

(3045424) Erythrocytes [Presence] in Urine

396

1.40

1.58

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

175

1.61

1.57

1.3

2.3

—

(3044927) Protein electrophoresis panel - Urine

175

1.61

1.57

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

122

1.73

1.54

1.1

1.7

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.93

1.54

1.1

—

0.21

g/l

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

138

1.67

1.51

1.2

1.1

—

(3004451) EKG impression Narrative

1.83

1.51

1.4

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.90

1.49

2.9

2.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.00

1.48

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.00

1.48

1.2

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

594

0.70

1.48

1.8

1.7

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

402

1.37

1.47

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

488

1.34

1.47

1.4

1.5

118.29

115.09

u/ml

0.09

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.37

1.45

1.2

1.7

49.53

125.04

ng/l

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.37

1.45

1.1

1.6

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.12

1.44

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.12

1.44

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.12

1.44

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.12

1.44

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.92

1.43

1.1

1.3

92.50

89.44

—

(3000285) Sodium [Moles/volume] in Blood

2.73

1.43

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.97

1.43

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.31

1.43

1.0

1.1

0.01

0.11

u/ml

—

(3020874) Milk IgE Ab [Units/volume] in Serum

172

1.57

1.43

1.1

1.0

0.12

3.79

u/ml

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

431

1.35

1.41

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.90

1.39

3.9

4.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

476

1.33

1.38

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

142

1.62

1.38

1.1

1.2

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.94

1.38

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

653

1.28

1.36

2.0

1.9

3.23

4.97

iu/l

2.08

251

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

374

1.37

1.36

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

223

1.48

1.36

2.4

2.2

32.45

32.62

0.09

223

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.87

1.34

1.1

89.88

90.79

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.92

1.33

1.6

1.2

16.96

17.17

umol/l

0.08

(3034274) Bile acid [Moles/volume] in Serum --fasting

333

1.39

1.33

1.8

2.3

6.77

6.59

umol/l

0.03

249

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

106

1.70

1.29

2.6

1.6

31.56

29.67

umol/l

0.27

101

(3041806) Other cells [#/volume] in Blood by Manual count

1.76

1.29

2.1

1.4

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

169

1.54

1.28

1.3

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

517

0.71

1.26

2.9

3.5

23.54

28.88

u/ml

0.34

500

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

158

0.51

1.24

1.3

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.40

1.24

1.3

1.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.75

1.19

1.0

9.85

14.53

u/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

264

1.41

1.18

1.6

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

264

1.41

1.18

1.6

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.78

1.16

1.1

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

420

1.31

1.16

1.6

1.4

25.38

28.71

u/l

0.37

346

(3005988) Vibrio sp identified in Specimen by Organism specific culture

265

1.40

1.16

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

274

1.39

1.15

1.6

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

370

1.33

1.12

1.0

1.1

3.16

4.11

u/ml

0.22

144

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.00

1.12

1.0

1.1

—

(3003694) ABO and Rh group [Type] in Blood

778

7337

1.08

1.10

1.5

—

(3025130) Human papilloma virus identified in Specimen

424

1.30

1.10

2.0

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

531

1.27

1.09

1.3

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

194

0.57

1.09

1.2

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

252

1.39

1.08

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.19

1.08

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

444

1.29

1.06

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.93

1.06

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

498

0.74

1.04

1.3

1.5

—

(3034426) Prothrombin time (PT)

1.67

1.04

1.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

367

1.31

1.03

1.8

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

272

1.36

1.02

1.6

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

272

1.36

1.02

1.6

1.5

—

(40768795) Lymph node Pathology biopsy report

275

0.65

1.01

1.1

1.2

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

502

1.26

1.00

5.3

6.4

124.60

878.84

iu/ml

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

265

1.36

0.99

4.6

5.5

178.34

58.56

u/ml

0.45

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

274

1.35

0.99

2.4

2.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.81

0.98

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.18

0.98

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

660

0.78

0.97

1.3

1.5

—

(3000012) Reticulocyte production index

241

1.37

0.96

3.8

2.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

319

1.32

0.96

1.9

1.4

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

259

2337

1.12

0.96

3.6

4.4

34.87

19.23

ug/l

0.23

207

1847

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

276

1.34

0.95

1.5

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

823

0.81

0.95

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

329

1.31

0.94

1.1

1.0

0.15

0.32

u/ml

0.60

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.89

0.94

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.72

0.92

2.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.14

0.91

1.3

1.0

—

(3017569) Oxygen content in Arterial blood

1.60

0.90

6.1

2.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

665

1.21

0.89

1.6

1.5

233.16

164.64

pmol/l

0.16

652

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

178

2000

0.88

1.5

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

468

1.24

0.86

1.9

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

647

0.80

0.85

1.4

1.5

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.94

0.84

1.0

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

1.78

0.84

1.0

1.2

115.00

98.84

—

(3037756) Immunofixation for Serum or Plasma

363

1.27

0.82

1.4

1.7

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

197

1.37

0.82

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

409

1.25

0.81

1.1

2.52

2.72

u/ml

0.06

193

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

215

1.35

0.80

2.4

2.8

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

7.7

—

(3050129) First trimester maternal screen panel - Serum or Plasma

922

0.84

0.78

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

199

1.36

0.78

1.9

1.5

—

(3006462) Nitrate [Presence] in Urine

1.56

0.78

4.5

2.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.59

0.78

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

475

1.23

0.77

2.3

2.1

0.85

0.78

nmol/l

0.35

401

(3019977) pH of Arterial blood

115

1.48

0.76

8.5

3.3

7.44

7.43

—

(3005033) Fetal Nuchal fold Thickness US

626

0.81

0.76

1.4

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

267

2905

0.91

0.75

1.9

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

542

1.20

0.73

1.8

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

108

1.48

0.73

1.4

1.8

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

108

1.48

0.73

1.4

1.8

—

(3036782) Glucose [Moles/volume] in Pleural fluid

167

1.38

0.73

1.7

1.4

5.92

6.38

mmol/l

0.47

158

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.00

0.72

1.0

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

1.80

0.72

4.6

5.7

67.57

70.91

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.61

0.72

1.1

1.3

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.61

0.72

1.1

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.61

0.72

1.1

1.3

—

(4035726) Immunohistochemistry procedure

210

2305

0.90

0.72

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.92

0.70

1.8

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

630

0.82

0.70

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

240

0.71

0.70

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

1.41

0.69

2.3

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

1.85

0.68

1.4

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

117

0.60

0.67

2.3

2.4

77.14

149.71

nmol/l

—

101

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

168

0.65

0.67

1.9

1.8

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

622

1.18

0.67

3.3

2.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

384

1.23

0.66

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

384

1.23

0.66

1.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

366

1.23

0.66

1.3

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

303

1.26

0.66

1.8

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

128

1.41

0.65

1.0

982.18

684.23

ng/l

2.10

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

129

1.40

0.63

1.0

246.17

339.57

ng/l

0.82

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.52

0.62

1.1

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

313

0.76

0.62

1.0

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

130

1.39

0.61

1.0

20.18

47.24

ng/l

5.10

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

262

1.26

0.61

1.7

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

262

1.26

0.61

1.7

1.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.57

0.60

1.4

1.8

32.77

47.17

u/l

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.60

0.0

8.5

—

71.58

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

463

1.19

0.60

1.4

0.29

0.39

nmol/l

1.10

357

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.50

0.59

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

1.54

0.59

1.1

1.3

65.42

54.40

mu/l

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

757

0.86

0.59

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

354

1.22

0.58

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

756

0.86

0.58

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

756

0.86

0.58

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

228

1.27

0.58

1.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

437

1.19

0.58

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.72

0.57

1.2

2.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

754

0.86

0.57

1.4

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

503

1.18

0.56

2.4

60.91

99.40

ug/min

0.62

308

(3043410) Blood group antigens tested for on Red Blood Cells

1.51

0.56

2.5

1.2

—

(3035880) pH of Pleural fluid

1.45

0.55

1.5

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

107

1.40

0.55

9.1

2.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

182

0.71

0.54

1.8

2.0

3.17

1.99

u/field

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

108

1.39

0.53

1.0

1.1

1532.48

1382.35

miu/ml

0.15

108

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

1.54

0.53

1.8

3.6

—

11.03

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

152

1.32

0.52

1.2

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

100

1.40

0.51

1.1

264.14

208.16

iu/ml

0.25

100

(3052592) Norovirus Ag [Presence] in Stool

1.50

0.51

2.3

1.4

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.50

0.51

1.0

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

126

1.35

0.51

1.2

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

445

1.17

0.49

1.7

1.5

—

(3011648) Oxygen content in Venous blood

180

1.28

0.49

13.4

2.2

10.68

11.03

0.20

180

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

243

1.24

0.49

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

1.43

0.49

5.0

11.7

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

418

1.17

0.49

1.1

20.43

1366.50

iu/ml

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

280

1.22

0.48

2.0

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

154

1.30

0.48

1.4

1.1

—

(3014271) Vancomycin [Susceptibility]

1.45

0.48

3.0

2.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

286

2695

1.07

0.48

1.7

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.46

0.46

1.9

1.3

2.39

2.82

mmol/l

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.61

0.45

1.8

3.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.60

0.45

1.4

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

246

1.22

0.45

1.2

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

301

1.20

0.45

1.6

1.9

—

1056.00

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

112

1.34

0.44

1.9

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

247

1.22

0.44

1.0

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

377

1.17

0.43

4.0

5.6

357.34

380.32

umol/l

0.55

327

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

527

1.14

0.43

1.9

1.7

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

490

1.15

0.42

1.5

1.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.56

0.42

2.8

1.5

—

(40768441) Liver Pathology biopsy report

203

1.23

0.42

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

194

1.24

0.42

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

194

1.24

0.42

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

194

1.24

0.42

1.4

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

680

1.12

0.41

4.0

3.6

1.31

1.45

mg/l

1.27

637

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.41

0.0

2.6

—

(1761868) Lipid panel - Serum or Plasma

1019

10432

0.97

0.40

2.7

2.6

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

172

0.75

0.40

1.2

1.3

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

12.7

—

179.38

—

(1761482) Bacteria [#/volume] in Urine by Culture

531

1.13

0.39

4.8

3.8

—

(4034850) Laboratory test

740

1.11

0.39

11.5

7.6

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

115

1.31

0.38

2.5

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

789

1.11

0.38

2.1

1.22

2.22

ug/l

0.92

720

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.39

0.38

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.39

0.38

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

116

1.29

0.37

1.9

1.4

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.27

0.36

6.0

6.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.27

0.36

1.7

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.27

0.36

3.0

3.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.43

0.35

1.5

2.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.43

0.35

1.3

3.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

871

1.09

0.35

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

117

1.28

0.35

2.5

1.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

117

1083

1.08

0.35

1.3

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

190

1.21

0.34

1.9

1.4

18468.71

68232.77

e6/l

0.91

102

(40768793) Breast Pathology biopsy report

681

1.10

0.34

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.28

0.32

1.3

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.28

0.32

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

370

0.86

0.32

1.2

1.4

2.90

3.95

ug/l

0.63

333

(3003434) Protein [Mass/volume] in Pleural fluid

229

1.18

0.32

1.9

1.5

29.17

32.17

g/l

0.64

210

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

257

1.17

0.32

1.7

1.8

—

(3012441) Differential panel - Pleural fluid

183

1.20

0.31

1.9

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

101

1.29

0.31

1.2

—

(21494434) Karyotype in Bone marrow

174

1.21

0.31

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

100

0.70

0.30

1.1

1.0

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.27

0.30

1.4

2.3

13.71

18.67

umol/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.29

0.30

1.1

—

(3042631) Mycobacterium sp identified in Specimen

259

1.16

0.29

3.3

2.6

—

(21494755) Public health laboratory ask at order entry panel

321

3334

0.96

0.29

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.32

0.28

1.4

1.9

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.28

0.28

2.7

2.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.27

7.7

3.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.25

0.27

1.1

1.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.25

0.27

7.7

3.1

—

(40765096) Chromosome analysis panel by Banding

1.30

0.26

1.0

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

160

1.19

0.25

2.5

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.20

0.25

1.1

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.27

0.24

1.6

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.27

0.24

1.6

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.32

0.23

1.0

1.1

—

(3017704) Immunofixation for Urine

1.24

0.23

1.3

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

238

1.14

0.22

1.7

1.8

—

(3045788) Cell count panel - Pleural fluid

172

1.16

0.22

2.0

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

163

1.17

0.21

2.3

1.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

22.08

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

3.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.21

0.0

2.8

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.21

0.0

1.0

—

22.77

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.21

0.0

1.1

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.00

0.21

0.0

1.9

—

1.29

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(3024471) HLA-A [Type]

102

0.78

0.21

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.21

0.0

1.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

6.0

—

490.62

—

(3001019) Free T4 and TSH panel - Serum or Plasma

191

1837

1.04

0.20

1.7

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

605

1.08

0.20

1.5

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

164

1.16

0.20

1.2

1.1

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.20

0.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

240

1.13

0.20

3.2

2.2

3.97

4.01

mmol/l

0.32

234

(3035285) Chloride [Moles/volume] in Venous blood

240

1.13

0.20

3.2

2.2

106.52

105.16

mmol/l

1.28

234

(3023199) Leukocytes [#/volume] in Pleural fluid

212

1.13

0.19

2.0

1.4

1021.28

1547.33

e6/l

0.59

148

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.18

0.19

1.2

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

385

1.09

0.19

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

100

1.20

0.18

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

185

1.14

0.18

6.8

7.1

—

(3022689) Creatine [Moles/volume] in Urine

1.16

0.16

1.5

—

(3033799) Differential panel - Peritoneal fluid

0.76

0.15

1.2

2.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

104

997

1.04

0.14

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

236

1.10

0.14

3.3

2.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

217

1.11

0.14

1.6

2.5

1.24

1.64

g/24h

—

113

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

122

1.15

0.13

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

122

1.15

0.13

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

122

1.15

0.13

1.6

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

170

0.88

0.13

1.3

1.5

—

(3024932) HLA-DR beta [Type]

100

0.80

0.13

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

108

0.83

0.13

1.6

1.8

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

219

0.91

0.11

1.2

1.3

1.64

1.59

g/l

0.40

219

(3039443) Prostate specific Ag panel - Serum or Plasma

426

1.06

0.10

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.14

0.10

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

164

1.10

0.09

1.4

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.06

0.09

2.2

1.4

—

(40768800) Prostate Pathology biopsy report

288

0.94

0.08

1.1

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

165

1.09

0.08

1.1

1.0

2.66

2.33

u/ml

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.82

0.08

1.4

1.2

—

(3015183) Erythrocyte sedimentation rate

146

1.10

0.08

1.3

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

117

1.11

0.08

2.6

1.5

—

783425.00

iu/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

195

0.92

0.08

1.6

1.4

142.56

158.12

pmol/l

0.14

195

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

156

1.09

0.08

2.6

41205.88

40431.41

ug/l

0.09

156

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.86

0.07

1.2

1.5

8.89

8.97

ug/l

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.05

0.07

1.4

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.04

0.07

1.1

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

1.03

0.07

1.4

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

245

1.06

0.07

1.7

1.4

1.00

0.98

g/l

0.17

245

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

118

1.10

0.07

1.6

1.2

3.54

5.11

umol/l

0.74

113

(3026250) Tacrolimus [Mass/volume] in Blood

122

0.90

0.07

42.2

35.7

7.06

7.43

ug/l

0.31

113

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

101

0.89

0.06

3.9

4.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

335

1.05

0.06

3.2

3.1

0.81

nmol/l

0.00

257

(3019897) Erythrocyte distribution width [Ratio] by Automated count

395

1.04

0.05

2.3

2.6

13.09

13.08

0.03

389

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

248

1.05

0.05

2.0

1.7

—

(3045142) Bone marrow Pathology biopsy report

260

1.04

0.03

1.3

1.4

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

171

1.05

0.03

1.7

1.4

75.72

77.61

umol/l

0.10

171

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

530

1.02

0.02

1.2

229.83

282.67

u/ml

1.01

327

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

173

1.04

0.01

1.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

313

1.02

0.01

1.3

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

567

0.99

0.01

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

105

1.05

0.00

1.4

1.8

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

799

1.00

0.00

4.0

284.34

668.67

u/ml

0.59

686

(3051651) Icteric interference index of Serum or Plasma

156

1.03

0.00

2.3

3.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

234

0.98

0.00

1.1

—

(4281824) Cell count and differential, peritoneal fluid

294

0.99

0.00

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.02

0.00

1.8

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.02

0.00

1.9

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.02

0.00

1.8

2.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

162

0.99

0.00

2.1

1.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

123

0.98

0.00

2.0

1.8

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

8.8

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

226.40

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

0.0

5.4

—

1.10

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.67

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

9.0

—

(3047185) IgG [Mass/volume] in Urine

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.0

—

7.68

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

330

1.00

-0.00

2.6

2.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.92

-0.00

1.7

1.1

—

(40769427) Triglyceride [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.5

—

1324.43

—

(3047189) Immunofixation for 24 hour Urine

0.93

-0.00

1.0

2.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

-0.00

0.0

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.91

-0.00

3.8

3.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

2.2

—

4.55

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.99

-0.00

1.0

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3042733) HLA Ab [Presence] in Serum

0.92

-0.00

6.8

4.8

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

0.87

-0.00

1.5

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_ENTESOPATHYLOWNAS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_ENTESOPATHYLOWNAS	1.184 [1.06, 1.33]	0.004
Birth year	0.991 [0.98, 1.0]	0.035

During the follow-up period (1.1.1998 — 31.12.2019), 1019 out of 9037 females with M13_ENTESOPATHYLOWNAS died.

Males

Parameter	HR [95% CI]	p-value
M13_ENTESOPATHYLOWNAS	1.203 [1.06, 1.36]	0.003
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 689 out of 5860 males with M13_ENTESOPATHYLOWNAS died.

Mortality risk

Mortality risk for people of age

years, who have M13_ENTESOPATHYLOWNAS.

N-year risk	Females	Males
1	0.101%	0.218%
5	0.636%	1.265%
10	1.486%	3.29%
15	2.856%	6.41%
20	5.179%	10.96%

Relationships between endpoints

↥

Index endpoint: M13_ENTESOPATHYLOWNAS – Other/unspecified enthesopathies of lower limb, excluding foot

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other/unspecified enthesopathies of lower limb, excluding foot

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints